SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending after reporting strong earnings and authorizing a significant share buyback, which has paradoxically seen its stock decline, igniting community debate over executive stock-based compensation and dilution concerns amidst optimism for its AI/AR Smartglasses innovation and competition from rivals like Meta.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is trending as the community, undeterred by FUD, aggressively champions its role as Solana's privacy layer, citing recent integrations, partnerships for private payments, and an anticipated revenue-sharing model as catalysts for significant future gains.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Recent news of Luckin Coffee's new premium flagship store and a key competitor ending aggressive pricing are fueling optimism for increased margins and market dominance. The community is eagerly discussing a potential uplisting to address the stock's perceived deep undervaluation amidst rapid growth and international expansion.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is trending following its recent earnings, which saw an EPS beat but a revenue miss attributed to contract transitions and a government shutdown. This mixed report has led to some investors expressing disappointment, while others view the resulting dip as a buying opportunity, emphasizing the company's substantial $47.2 billion backlog and its pivotal role in key sectors like nuclear energy and space systems for long-term growth.

River is building a chain-abstraction stablecoin system that enables cross-chain collateral, yield, and liquidity—all without bridging.   Powered by the omni-CDP stablecoin satUSD, users can earn, leverage, and scale across different ecosystems natively.   River features the first omni-CDP module that allows users to collateralize assets on Chain A and mint stablecoin satUSD on Chain B—without bridging the assets.

River

RIVER is trending due to recent strategic funding and high-profile backing, alongside ongoing community debate about its innovative stablecoin abstraction system. While many anticipate significant gains fueled by low circulating supply and potential major exchange listings, others foresee a dump, citing concerns over potential token unlocks and supply dynamics.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending after its Q4 earnings report, which, despite profitability, featured a revenue miss and conservative guidance driven by prudent risk management, prompting a sharp sell-off that the community largely decries as an exaggerated market overreaction to an already undervalued AI-powered fintech. Many investors are viewing the dip as a significant buying opportunity amidst high short interest and broader pressures on the fintech sector.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending following the abrupt departures of its CFO and General Counsel amid an ongoing accounting review, an SEC investigation, and a lowered fiscal outlook, which has caused a significant stock plunge. The community is sharply divided, with some seeing an extreme overreaction and a buying opportunity, while others warn of severe accounting issues and potential fraud.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is garnering attention following a significant equity financing deal that strengthens its balance sheet and liquidity, building on a record year for retail sales and the expansion of Polestar 4 deliveries. Investors are weighing this positive financial injection and sales growth in several key markets against persistent concerns about the EV maker's path to sustained profitability and intense sector competition.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors anticipate its upcoming earnings report, with widespread debate on whether it will mirror Uber's recent stock performance amid intensifying concerns and opportunities presented by autonomous vehicle advancements. Community discussions are active around its potential as an acquisition target and the impact of its international partnerships.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending following its announced partnership with Palantir for specialized AI data engineering and a prime federal contract with the U.S. Missile Defense Agency. The community is buzzing with anticipation for a potentially explosive Q4 earnings report, expecting significant growth from INOD's critical role in AI data training for government, defense, and sovereign AI initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New York State Common Retirement Fund Has $4.60 Million Stock Holdings in Emergent Biosolutions Inc. $EBS

New York State Common Retirement Fund lifted its stake in shares of Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 32.6% in the third quarter, according to its most recent Form 13F filing...

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above 200-Day Moving Average - Here's Why

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above 200-Day Moving Average - Should You Sell...

<ul class="summary-bullets"><li>The Attorney General’s lawsuit alleges that Kramer knew about the manufacturing and contamination issues and yet executed a trading plan before those issues were made public in violation of the law.</li><li>James is now seeking damages, disgorgement, and costs from Kramer.</li><li>Emergent inked contracts worth $261 million with AstraZeneca in 2020 to manufacture the latter’s Covid-19 vaccine.</li></ul>Shares of Emergent Biosolutions Inc (EBS) slumped 13% on Thursday after New York State Attorney General Letitia James sued the company’s former CEO Robert G. Kramer for insider trading.James also inked a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ag.ny.gov/press-release/2026/attorney-general-james-sues-former-ceo-emergent-biosolutions-insider-trading">settlement</a> with Emergent under which the company will pay $900,000 in penalties for approving Kramer’s trading plan. Emergent will improve its executive trading policies, James said.<h2 class="st-heading-2">Transactions In Question</h2>Emergent inked contracts worth $261 million with AstraZeneca in 2020 to manufacture the latter’s Covid-19 vaccine. However, large amounts of the vaccines Emergent produced were contaminated, rendering them unusable.According to a probe by the Office of the Attorney General, Kramer was made aware of the contamination in October 2020 and the company omitted the unresolved contamination issues in communications through November. It instead approved Kramer’s trading plan under which he sold his company shares for over $10 billion, James said, while adding that Emergent's shares began to drop shortly after Kramer completed his sales in February 2021.The U.S. Food and Drug Administration (FDA) ordered a permanent halt to Emergent’s production of the AstraZeneca (AZN) vaccine in April 2021. The Attorney General’s lawsuit alleges that Kramer knew about the manufacturing and contamination issues and executed a trading plan before those issues were made public in violation of the law. James is now seeking damages, disgorgement, and costs from Kramer.“At the height of the COVID-19 pandemic, Robert Kramer illegally profited millions by selling his company shares, while knowing that Emergent faced issues producing the AstraZeneca vaccine for millions of people. Kramer’s actions were illegal and unethical, and we are holding him accountable,” James said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around EBS rose from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user dismissed the penalty amount as irrelevant to the company’s financials.<stembedurl>https://www.stocktwits.com/KnuckleSandwich/message/641972166</stembedurl>Another termed the sell-off an “easy buying opportunity.”<stembedurl>https://www.stocktwits.com/AlarmedSheiky/message/641962084</stembedurl><a href="https://stocktwits.com/symbol/EBS">EBS stock</a> has gained 15% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/ibrx-stock-continues-rally-on-preliminary-revenue-numbers/cmU1wPAR4Jh">IBRX Stock Continues Rally — What’s Driving The Optimism Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The exterior view of the Emergent BioSolutions plant on April 01, 2021 in Baltimore, Maryland. (Photo by Tasos Katopodis/Getty Images)

Why Did EBS Stock Fall 13% Today?

New York State Attorney General Letitia James inked a settlement with Emergent under which the company will pay $900,000 in penalties. 

Emergent Biosolutions Stock Plummets Amid Insider Trading Allegations Against Former CEO

Equity

New York State Attorney General Letitia James inked a settlement with Emergent under which the company will pay $900,000 in penalties. 


Emergent Biosolutions (NYSE:EBS) Stock Price Down 7.4% - What's Next?

Emergent Biosolutions (NYSE:EBS) Stock Price Down 7.4% - Time to Sell...

Emergent Biosolutions (NYSE:EBS) Reaches New 52-Week High - Time to Buy?

Emergent Biosolutions (NYSE:EBS) Hits New 52-Week High - Time to Buy...

Silver Oak Securities Incorporated Purchases New Position in Emergent Biosolutions Inc. $EBS

Silver Oak Securities Incorporated purchased a new stake in Emergent Biosolutions Inc. (NYSE:EBS - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities...

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Emergent Biosolutions (NYSE:EBS) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened...

Assenagon Asset Management S.A. Has $498,000 Stock Position in Emergent Biosolutions Inc. $EBS

Assenagon Asset Management S.A. lessened its stake in Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 81.8% in the third quarter, according to the company in its most recent disclosure with...

Emergent Biosolutions (NYSE:EBS) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why

Emergent Biosolutions (NYSE:EBS) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why...

Emergent Biosolutions (NYSE:EBS) Earns Buy Rating from HC Wainwright

HC Wainwright reaffirmed a "buy" rating and issued a $15.00 price objective on shares of Emergent Biosolutions in a research note on Tuesday...

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.11	--	--	N/A
Q3 '25	-$0.07	$1.06	1689.99%	BEAT
Q2 '25	-$0.41	$0.16	138.71%	BEAT
Q1 '25	$0.44	$0.71	61.36%	BEAT
Q4 '24	-$0.43	$0.05	111.63%	BEAT

EBS
Emergent Biosolutions Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest EBS News

EBSEmergent Biosolutions Inc